Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions.
Barcelona
Sandra L
SL
Department of Anesthesiology, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. sandra.barcelona@cmh.com
Thompson
Alexis A
AA
Coté
Charles J
CJ
D001803:Blood Transfusion; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy*; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D006470:Hemorrhage / Q000209:etiology* / Q000628:therapy; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007430:Intraoperative Care; D016030:Kidney Transplantation; D011183:Postoperative Complications / Q000628:therapy; D011994:Recombinant Proteins / Q000627:therapeutic use; D014068:Tonsillectomy; D014947:Wounds and Injuries / Q000150:complications
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa